2023: Organized the 19th Congress of Immunology Society in Paris
2020: Launch of the Diabetes Institute of the University of Paris
|
2023: Opened satellite Lab at the Indiana Buiscience Institute at Indianapolis, USA
2019: Lab awarded the label " Equipe FRM" (Fondation Recherche Médical)
|
2024: Frist patient treated with Teplizumab
2018: The first beta cell immuno-peptidome published in Cell Metabolism
|
2023: Organized the "3rd Resolution Days, the resolution of inflammation: opportunities for innovative therapeutics", Besançon, France
2018: Cover article published in Science Immunology
|
2017: Sylvaine You, INSERM Researcher, joins the team
|
2016: R. Mallone awarded with the Auguste Loubatières Prize of the Francophone Society of Diabetes
|
 2015: Joins the EU Innovative Medicines Initiative (IMI2) INNODIA
|
 2014: G. Afonso recruted as Lab Technician of Paris Descartes University
|
 2013: Launch of the Hospital University Department "Autoimmunity and Hormonal Diseases" (DHU Authors)
|
 2012: R. Mallone promoted to Inserm Research Director
|
2012: Apollinaire Bouchardat Prize
|
2012: Morgagni Young Investigator Award
|
2011: Vedran Brezar, first PhD Student graduated from the Lab
|
2010: Contrat de Recherche Translationnelle awarded by Inserm
|
2009: Avenir label awarded by Inserm
|
2008: R. Mallone awarded with the Rising Star Award of the European Association
for the Study of Diabetes (EASD)
|
2008: first grant from the Juvenile Diabetes Research Foundation (JDRF)
|
2007: joins the T-Cell Workshop Committee
of the Immunology of Diabetes Society
|
2007: publishes the ISL8Spot, a T-cell assay identifying
islet autoimmunity in human type 1 diabetes
|
